Publications

Publications

Curated scientific publications co-authored with clients and academic partners.

  1. A goat-derived gamma-tubulin antibody for triple-channel imaging of primary cilia

    Karapetian E, Gerhardt C, Lemanska N, Budnik M, Stahl E, Füner J, Hirschberg S, Pfirrmann T

    BMC Mol Cell Biol 2026

  2. Analysing open-source protein folding models for nanobody binding prediction

    Vogt Y, Roßberg R, Habermann J, Kluge P, Xu W, Naouar M, Hirschberg S, Miething C, Bödecker J, Kalweit M, Ullrich E, Kalweit G

    Frontiers in Bioinformatics 2026

  3. Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins

    Monica L, Oleshko O, Aires L, Wuschko S, Füner J, Paul H, Schauerte P, Jespersen DS, Belyanskaya L, Tiede A, Werwitzke S

    Res Pract Thromb Haemost 2025

  4. Spray-Dried Serum for Inhaled Antiviral Therapy

    Germani S, Polichetti M, Garrapa V, Trevisi G, Füner J, Bettini R

    Pharmaceutics 2025

  5. Broad Neutralization Capacity of an Engineered Thermostable Three-Helix Angiotensin-Converting Enzyme 2 Polypeptide Targeting the Receptor-Binding Domain of SARS-CoV-2

    Cavazzini D, Levati E, Germani S, Ta BL, Monica L, Bolchi A, Donofrio G, Garrapa V, Ottonello S, Montanini B

    Int J Mol Sci 2024

  6. Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire

    Eden T, Schaffrath AZ, Wesolowski J, Stähler T, Tode N, Richter N, Schäfer W, Hambach J, Hermans-Borgmeyer I, Woens J, Le Gall CM, Wendler S, Linke-Winnebeck C, Stobbe M, Budnicki I, Wanney A, Heitz Y, Schimmelpfennig L, Schweitzer L, Zimmer D, Stahl E, Seyfried F, Gebhardt AJ, Dieckow L, Riecken K, Fehse B, Bannas P, Magnus T, Verdoes M, Figdor CG, Hartlepp KF, Schleer H, Füner J, Tomas NM, Haag F, Rissiek B, Mann AM, Menzel S, Koch-Nolte F

    Nat Commun 2024

  7. A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide

    Glieca S, Cavazzini D, Levati E, Garrapa V, Bolchi A, Franceschi V, Odau S, Ottonello S, Donofrio G, Füner J, Sonvico F, Bettini R, Montanini B, Buttini F

    Eur J Pharm Sci 2023

  8. An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line

    Hirschberg S, Ghazaani F, Ben Amor G, Pydde M, Nagel A, Germani S, Monica L, Schlör A, Bauer H, Hornung J, Voetz M, Dwai Y, Scheer B, Ringel F, Kamal-Eddin O, Harms C, Füner J, Adrian L, Pruß A, Schulze-Forster K, Hanack K, Kamhieh-Milz J

    Vaccines (Basel) 2023

  9. Characterization of binding interactions of SARS-CoV-2 spike protein and DNA-peptide nanostructures

    Kruse M, Altattan B, Laux EM, Grasse N, Heinig L, Möser C, Smith DM, Hölzel R

    Sci Rep 2022

  10. Aluminium from adjuvanted subcutaneous allergen immunotherapeutics in rats is mainly detected in bone

    Weisser K, Göen T, Oduro JD, Wangorsch G, Hanschmann KM, Keller-Stanislawski B

    Allergy 2020

  11. Wheel running behaviour in group-housed female mice indicates disturbed wellbeing due to DSS colitis

    Weegh N, Füner J, Janke O, Winter Y, Jung C, Struve B, Wassermann L, Lewejohann L, Bleich A, Häger C

    Lab Anim 2020

  12. Aluminium in plasma and tissues after intramuscular injection of adjuvanted human vaccines in rats

    Weisser K, Göen T, Oduro JD, Wangorsch G, Hanschmann KM, Keller-Stanislawski B

    Arch Toxicol 2019

  13. Aluminium toxicokinetics after intramuscular, subcutaneous, and intravenous injection of Al citrate solution in rats

    Weisser K, Göen T, Oduro JD, Wangorsch G, Hanschmann KM, Keller-Stanislawski B

    Arch Toxicol 2019

  14. Generation and validation of murine monoclonal and camelid recombinant single domain antibodies specific for human pancreatic glycoprotein 2

    Schlör A, Holzlöhner P, Listek M, Grieß C, Butze M, Micheel B, Hentschel C, Sowa M, Roggenbuck D, Schierack P, Füner J, Schliebs E, Goihl A, Reinhold D, Hanack K

    N Biotechnol 2018

  15. Generation of murine monoclonal antibodies with specificity against conventional camelid IgG1 and heavy-chain only IgG2/3

    Holzlöhner P, Butze M, Maier N, Hebel N, Schliebs E, Micheel B, Füner J, Heidicke G, Hanack K

    Vet Immunol Immunopathol 2018

  16. Generation of precursor, immature, and mature murine B1-cell lines from c-myc/bcl-xL-overexpressing pre-BI cells

    Wolf I, Bouquet C, Naumann F, Melchers F

    Eur J Immunol 2017

  17. A Comparison of Fresh Frozen vs. Formalin-Fixed, Paraffin-Embedded Specimens of Canine Mammary Tumors via Branched-DNA Assay

    Lüder Ripoli F, Mohr A, Hammer SC, Willenbrock S, Hewicker-Trautwein M, Hennecke S, Murua Escobar H, Nolte I

    Int J Mol Sci 2016

  18. Multiplex Gene Expression Profiling of 16 Target Genes in Neoplastic and Non-Neoplastic Canine Mammary Tissues Using Branched-DNA Assay

    Lüder Ripoli F, Hammer SC, Mohr A, Willenbrock S, Hewicker-Trautwein M, Brenig B, Murua Escobar H, Nolte I

    Int J Mol Sci 2016

  19. A new experimental model to allow use of clinical-scale endoscopes in small-animal tumor models

    Anders M, Frimberger E, Odau S, Wiedenmann B, Rösch T

    J Gastrointest Oncol 2011